Natalizumab-induced pneumonitis

Stefania Kaninia; Anthony Edey; Nick A Maskell; Claire M Rice

doi:10.1007/s00415-021-10811-3

Natalizumab-induced pneumonitis

Stefania Kaninia, Anthony Edey, Nick A Maskell, Claire M Rice^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate (Academic Journal) › peer-review

2 Downloads (Pure)

Abstract

[No abstract]

Original language	English
Journal	Journal of Neurology
DOIs	https://doi.org/10.1007/s00415-021-10811-3
Publication status	Published - 22 Sep 2021

Bibliographical note

Funding Information:
We are grateful to the patient for permission to publish the case report. SK is supported by a fellowship from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

Access to Document

10.1007/s00415-021-10811-3

Full-text PDF (accepted author manuscript)
This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Springer at 10.1007/s00415-021-10811-3. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 542 KBLicence: Unspecified

Handle.net

Persistent link

Cite this

@article{3a8f9b16c65240d8bff3cee8758402e9,

title = "Natalizumab-induced pneumonitis",

abstract = "[No abstract]",

author = "Stefania Kaninia and Anthony Edey and Maskell, {Nick A} and Rice, {Claire M}",

note = "Funding Information: We are grateful to the patient for permission to publish the case report. SK is supported by a fellowship from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). ",

year = "2021",

month = sep,

day = "22",

doi = "10.1007/s00415-021-10811-3",

language = "English",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Natalizumab-induced pneumonitis

AU - Kaninia, Stefania

AU - Edey, Anthony

AU - Maskell, Nick A

AU - Rice, Claire M

N1 - Funding Information: We are grateful to the patient for permission to publish the case report. SK is supported by a fellowship from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

PY - 2021/9/22

Y1 - 2021/9/22

N2 - [No abstract]

AB - [No abstract]

U2 - 10.1007/s00415-021-10811-3

DO - 10.1007/s00415-021-10811-3

M3 - Comment/debate (Academic Journal)

C2 - 34550470

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

ER -

Natalizumab-induced pneumonitis

Abstract

Bibliographical note

Access to Document

Handle.net

Fingerprint

Cite this